This study aims to see if a dietary supplement called citicoline can help improve sleep and thinking skills in people with Alzheimer's Disease (AD). Alzheimer's is a condition that affects memory and thinking. Many people with AD have trouble sleeping, which affects their quality of life and can lead to them needing more care. Citicoline has been tested before and found safe in AD patients.
The study is a 3-month trial where participants will be given either citicoline or a placebo (a sugar pill that looks like the real thing but has no effect). The trial is double-blind, meaning neither the participants nor the researchers know who gets the real supplement. Participants will be checked at the start and after 3 months to see if there's any improvement in sleep and thinking skills.
- Duration: 3 months with two main visits.
- Participation: For people 18+ with an AD diagnosis.
- Compensation: None mentioned, but the supplement is provided.
To join, participants need to be diagnosed with AD, be at least 18 years old, and have access to the internet. People with certain health issues or irregular work schedules cannot join.